Related Experiment Video
Updated: Dec 18, 2025

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis
Ting C Zhao1, Zhengke Wang2, Tina Y Zhao3
1Department of Surgery and Plastics Surgery, Brown University, Rhode Island Hospital, Providence, RI, USA.
Insights
Histone deacetylases (HDACs) regulate gene transcription in cardiovascular disease. Selective HDAC inhibitors show promise for preventing cardiac hypertrophy and treating vascular dysfunction.
Area of Science:
- Cardiovascular biology
- Epigenetics
- Molecular medicine
Background:
- Cardiovascular diseases are a leading global cause of mortality.
- Endothelial dysfunction and inflammation drive atherosclerotic lesion development.
- Histone deacetylases (HDACs) are critical epigenetic regulators in cardiovascular pathology.
Purpose of the Study:
- To review the role of HDACs in vascular cell function.
- To discuss the therapeutic potential of HDAC inhibitors in cardiovascular disease.
- To explore the molecular mechanisms underlying HDAC regulation in the vasculature.
Main Methods:
- Literature review of cellular and molecular mechanisms.
- Analysis of HDACs' co-regulatory networks and protein targets.
- Examination of pharmacologic interventions targeting HDACs.
Main Results:
- HDACs play a significant role in the epigenetic regulation of gene transcription in response to vascular stress.
- HDACs form complex networks with transcription factors, influencing vascular system regulation.
- Selective HDAC inhibitors are identified as promising therapeutic targets, particularly for cardiac hypertrophy.
Conclusions:
- HDACs are key mediators of biological functions in vascular cells.
- Targeting HDACs offers a promising strategy for managing cardiovascular diseases.
- Further research into HDACs and their inhibitors is crucial for developing effective vascular disease treatments.
Abstract:
Cardiovascular diseases are the leading cause of deaths in the world. Endothelial dysfunction followed by inflammation of the vessel wall leads to atherosclerotic lesion formation that causes ischemic heart and myocardial hypertrophy, which ultimately progress into cardiac dysfunction and failure. Histone deacetylases (HDACs) have been recognized to play crucial roles in cardiovascular disease, particularly in the epigenetic regulation of gene transcription in response to a variety of stresses. The unique nature of HDAC regulation includes that HDACs form a complex co-regulatory network with other transcription factors, deacetylate histones and non-histone proteins to facilitate the regulatory mechanism of the vascular system. The selective HDAC inhibitors are considered as the most promising target in cardiovascular disease, especially for preventing cardiac hypertrophy. In this review, we discuss our present knowledge of the cellular and molecular basis of HDACs in mediating the biological function of vascular cells and related pharmacologic interventions in vascular disease.
More Related Videos
14:32Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
09:43Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue
Published on: November 30, 2018
Related Concept Videos
Atherosclerosis III: Management
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Regulation of Angiogenesis and Blood Supply
Hypertension II: Pathophysiology
Atherosclerosis I: Introduction